Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.29 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 349230 | ||
| 12:12 PM - Feb 23, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Stockholders Approve Company Proposals at 2009 Annual Meeting
Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure--
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors

Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
Enzon Commences Phase II Trial of PEG-SN38
-- Conference Call With Principal Investigators to be Held Tomorrow--
Enzon to Present at 29th Annual Cowen and Company Conference
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business --
